SI9011006B - Novi 8-substituirani-2-aminotetralini - Google Patents
Novi 8-substituirani-2-aminotetralini Download PDFInfo
- Publication number
- SI9011006B SI9011006B SI9011006A SI9011006A SI9011006B SI 9011006 B SI9011006 B SI 9011006B SI 9011006 A SI9011006 A SI 9011006A SI 9011006 A SI9011006 A SI 9011006A SI 9011006 B SI9011006 B SI 9011006B
- Authority
- SI
- Slovenia
- Prior art keywords
- formula
- alkyl
- compound
- aryl
- hydrogen
- Prior art date
Links
- -1 8-substituted-2-amino-tetralines Chemical class 0.000 title claims 8
- 150000001875 compounds Chemical class 0.000 claims abstract 25
- 125000003118 aryl group Chemical group 0.000 claims abstract 15
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 13
- 239000001257 hydrogen Substances 0.000 claims abstract 13
- 229910052736 halogen Inorganic materials 0.000 claims abstract 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 10
- 150000002367 halogens Chemical class 0.000 claims abstract 7
- 150000003839 salts Chemical class 0.000 claims abstract 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 5
- 208000035475 disorder Diseases 0.000 claims abstract 5
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 5
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 5
- 125000005842 heteroatom Chemical group 0.000 claims abstract 4
- 238000000034 method Methods 0.000 claims abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 208000024827 Alzheimer disease Diseases 0.000 claims 4
- 238000006243 chemical reaction Methods 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 229910052723 transition metal Inorganic materials 0.000 claims 4
- 150000003624 transition metals Chemical class 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 206010001497 Agitation Diseases 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 101100440696 Caenorhabditis elegans cor-1 gene Proteins 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 208000020401 Depressive disease Diseases 0.000 claims 2
- 208000019695 Migraine disease Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 206010039966 Senile dementia Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 238000013019 agitation Methods 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 208000022531 anorexia Diseases 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 210000000748 cardiovascular system Anatomy 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 206010061428 decreased appetite Diseases 0.000 claims 2
- 206010027599 migraine Diseases 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 238000006464 oxidative addition reaction Methods 0.000 claims 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 2
- 208000012201 sexual and gender identity disease Diseases 0.000 claims 2
- 208000015891 sexual disease Diseases 0.000 claims 2
- 230000001331 thermoregulatory effect Effects 0.000 claims 2
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 239000001569 carbon dioxide Substances 0.000 claims 1
- 229910002091 carbon monoxide Inorganic materials 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 125000001207 fluorophenyl group Chemical group 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims 1
- 125000002524 organometallic group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 238000006478 transmetalation reaction Methods 0.000 claims 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8901889A SE8901889D0 (sv) | 1989-05-26 | 1989-05-26 | Novel 8-substituted-2-aminotetralines |
| YU100690A YU48830B (sh) | 1989-05-26 | 1990-05-23 | Novi 8-supstituisani-2-aminotetralini |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI9011006A SI9011006A (en) | 1997-12-31 |
| SI9011006B true SI9011006B (sl) | 1998-12-31 |
Family
ID=20376074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9011006A SI9011006B (sl) | 1989-05-26 | 1990-05-23 | Novi 8-substituirani-2-aminotetralini |
Country Status (41)
| Country | Link |
|---|---|
| US (1) | US5635537A (cs) |
| EP (1) | EP0399982B1 (cs) |
| JP (1) | JP2818692B2 (cs) |
| KR (1) | KR100193981B1 (cs) |
| CN (1) | CN1023399C (cs) |
| AT (1) | ATE129696T1 (cs) |
| AU (1) | AU644081B2 (cs) |
| CA (1) | CA2032498C (cs) |
| CY (1) | CY1989A (cs) |
| CZ (1) | CZ286038B6 (cs) |
| DD (1) | DD298909A5 (cs) |
| DE (1) | DE69023274T2 (cs) |
| DK (1) | DK0399982T3 (cs) |
| DZ (1) | DZ1417A1 (cs) |
| ES (1) | ES2078962T3 (cs) |
| FI (1) | FI114151B (cs) |
| GR (1) | GR3018566T3 (cs) |
| HK (1) | HK55697A (cs) |
| HR (1) | HRP920622B1 (cs) |
| HU (2) | HUT58685A (cs) |
| IE (1) | IE75057B1 (cs) |
| IL (1) | IL94428A (cs) |
| IS (1) | IS1663B (cs) |
| JO (1) | JO1617B1 (cs) |
| LT (1) | LT3966B (cs) |
| LV (2) | LV10243B (cs) |
| MX (1) | MX20842A (cs) |
| NO (1) | NO176603C (cs) |
| NZ (1) | NZ233724A (cs) |
| PH (1) | PH31110A (cs) |
| PL (2) | PL164245B1 (cs) |
| PT (1) | PT94163B (cs) |
| RU (1) | RU2093507C1 (cs) |
| SA (1) | SA90100274B1 (cs) |
| SE (1) | SE8901889D0 (cs) |
| SI (1) | SI9011006B (cs) |
| SK (1) | SK280731B6 (cs) |
| UA (1) | UA40562C2 (cs) |
| WO (1) | WO1990014330A1 (cs) |
| YU (1) | YU48830B (cs) |
| ZA (1) | ZA903801B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT61719A (en) | 1989-05-31 | 1993-03-01 | Upjohn Co | Process for producing 2-aminotetraline derivatives and pharmaceutical compositions comprising such compounds |
| DE69124868T2 (de) * | 1990-08-15 | 1997-07-10 | Lilly Co Eli | Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane |
| US5643784A (en) * | 1990-12-04 | 1997-07-01 | H, Lundbeck A/S | Indan derivatives |
| PT712837E (pt) * | 1991-02-08 | 2001-03-30 | Lilly Co Eli | 2-amino-1,2,3,4-tetra-hidronaftalenos de 3-aminocromanos de anel substituido |
| US5347013A (en) * | 1991-03-28 | 1994-09-13 | Eli Lilly And Company | 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles |
| US5627199A (en) * | 1991-03-28 | 1997-05-06 | Eli Lilly And Company | 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz [CD] indoles |
| US5244911A (en) * | 1991-03-28 | 1993-09-14 | Eli Lilly And Company | 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof |
| US5244912A (en) * | 1991-03-28 | 1993-09-14 | Eli Lilly And Company | 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| SE9103745D0 (sv) * | 1991-12-18 | 1991-12-18 | Wikstroem Haakan | Aryl-triflates and related compounds |
| DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| SE9301732D0 (sv) * | 1993-05-18 | 1993-05-18 | Haakan Wilhelm Wikstroem | New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins |
| WO1996015099A1 (en) * | 1994-11-09 | 1996-05-23 | Novo Nordisk A/S | Heterocyclic compounds, their preparation and use |
| GB9509156D0 (en) * | 1995-05-05 | 1995-06-28 | Sandoz Ltd | Organic compounds |
| PL1831152T3 (pl) * | 2004-12-21 | 2009-03-31 | Hoffmann La Roche | Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT |
| SI1831159T1 (sl) * | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Derivati tetralina in indana ter njune uporabe |
| AU2006335174B2 (en) | 2006-01-06 | 2012-09-06 | Sunovion Pharmaceuticals Inc. | Tetralone-based monoamine reuptake inhibitors |
| MX2023010837A (es) | 2021-03-17 | 2023-09-29 | Receptos Llc | Métodos de tratamiento de la dermatitis atopica. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2752659A1 (de) * | 1976-12-07 | 1978-06-08 | Sandoz Ag | Neue tetralinderivate, ihre herstellung und verwendung |
| US4247907A (en) * | 1978-11-27 | 1981-01-27 | International Business Machines Corporation | Method and apparatus for typing characters and optically readable binary representations thereof on same page |
| SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
| IL65501A (en) * | 1981-05-08 | 1986-04-29 | Astra Laekemedel Ab | 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them |
| DE3479314D1 (en) * | 1984-05-22 | 1989-09-14 | Nelson Res & Dev | Substituted 2-aminotetralins and processes for synthesis |
| DE3660959D1 (de) * | 1985-06-26 | 1988-11-24 | Smithkline Beckman Corp | Benz-trisubstituted 2-aminotetralins |
| IL79323A (en) * | 1985-07-10 | 1990-03-19 | Sanofi Sa | Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them |
| DE3718317A1 (de) * | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| CA2026775C (en) * | 1989-01-09 | 1998-04-07 | Per Arvid Emil Carlsson | Halo substituted aminotetralins |
| HUT61719A (en) * | 1989-05-31 | 1993-03-01 | Upjohn Co | Process for producing 2-aminotetraline derivatives and pharmaceutical compositions comprising such compounds |
-
1989
- 1989-05-26 SE SE8901889A patent/SE8901889D0/xx unknown
-
1990
- 1990-05-17 ZA ZA903801A patent/ZA903801B/xx unknown
- 1990-05-17 IL IL9442890A patent/IL94428A/en not_active IP Right Cessation
- 1990-05-18 NZ NZ233724A patent/NZ233724A/xx unknown
- 1990-05-22 IE IE183390A patent/IE75057B1/en not_active IP Right Cessation
- 1990-05-23 DZ DZ900088A patent/DZ1417A1/fr active
- 1990-05-23 HU HU904810A patent/HUT58685A/hu unknown
- 1990-05-23 JP JP2508698A patent/JP2818692B2/ja not_active Expired - Lifetime
- 1990-05-23 AT AT90850209T patent/ATE129696T1/de not_active IP Right Cessation
- 1990-05-23 DK DK90850209.9T patent/DK0399982T3/da active
- 1990-05-23 RU SU904894777A patent/RU2093507C1/ru active
- 1990-05-23 ES ES90850209T patent/ES2078962T3/es not_active Expired - Lifetime
- 1990-05-23 MX MX2084290A patent/MX20842A/es unknown
- 1990-05-23 CA CA002032498A patent/CA2032498C/en not_active Expired - Lifetime
- 1990-05-23 EP EP90850209A patent/EP0399982B1/en not_active Expired - Lifetime
- 1990-05-23 WO PCT/SE1990/000351 patent/WO1990014330A1/en active IP Right Grant
- 1990-05-23 UA UA4894777A patent/UA40562C2/uk unknown
- 1990-05-23 DE DE69023274T patent/DE69023274T2/de not_active Expired - Lifetime
- 1990-05-23 SI SI9011006A patent/SI9011006B/sl unknown
- 1990-05-23 YU YU100690A patent/YU48830B/sh unknown
- 1990-05-23 AU AU58185/90A patent/AU644081B2/en not_active Expired
- 1990-05-23 IS IS3580A patent/IS1663B/is unknown
- 1990-05-23 KR KR1019910700092A patent/KR100193981B1/ko not_active Expired - Fee Related
- 1990-05-24 PL PL90300984A patent/PL164245B1/pl unknown
- 1990-05-24 PL PL90285330A patent/PL165166B1/pl unknown
- 1990-05-25 CZ CS902560A patent/CZ286038B6/cs not_active IP Right Cessation
- 1990-05-25 SK SK2560-90A patent/SK280731B6/sk not_active IP Right Cessation
- 1990-05-25 PT PT94163A patent/PT94163B/pt not_active IP Right Cessation
- 1990-05-25 DD DD90340992A patent/DD298909A5/de unknown
- 1990-05-25 PH PH40567A patent/PH31110A/en unknown
- 1990-05-26 JO JO19901617A patent/JO1617B1/en active
- 1990-05-26 CN CN90103956A patent/CN1023399C/zh not_active Expired - Lifetime
- 1990-06-09 SA SA90100274A patent/SA90100274B1/ar unknown
-
1991
- 1991-01-25 FI FI910381A patent/FI114151B/fi active
- 1991-01-25 NO NO910310A patent/NO176603C/no not_active IP Right Cessation
-
1992
- 1992-09-30 HR HRP-1006/90A patent/HRP920622B1/xx not_active IP Right Cessation
-
1993
- 1993-03-18 US US08/033,013 patent/US5635537A/en not_active Expired - Lifetime
- 1993-06-30 LV LVP-93-869A patent/LV10243B/xx unknown
- 1993-12-30 LT LTIP1723A patent/LT3966B/lt not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00719P patent/HU211880A9/hu unknown
- 1995-12-29 GR GR950403703T patent/GR3018566T3/el unknown
-
1996
- 1996-11-01 LV LVP-96-420A patent/LV11736B/en unknown
-
1997
- 1997-05-01 HK HK55697A patent/HK55697A/en not_active IP Right Cessation
- 1997-09-05 CY CY198997A patent/CY1989A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI9011006B (sl) | Novi 8-substituirani-2-aminotetralini | |
| RU2005109913A (ru) | Азабициклоалкильные эфиры и их применение в качестве агонистов альфа7-nachr | |
| KR920701193A (ko) | 신규 크로만 및 티오크로만 유도체 | |
| Bálint et al. | Synthesis, absolute configuration and intermediates of 9-fluoro-6, 7-dihydro-5-methyl-1-oxo-1H, 5H-benzo [i, j] quinolizine-2-carboxylic acid (flumequine) | |
| HUP9800781A2 (hu) | Propanol-amin-származékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények, valamint ezek alkalmazása | |
| Alahyen et al. | 20 Years of Forging N-Heterocycles from Acrylamides through Domino/Cascade Reactions | |
| JPS62192359A (ja) | １，４−ジヒドロピリジン化合物の製法 | |
| NZ307230A (en) | Furo[3,4-c]pyrrole, isoindole or thieno[3,4-c]pyrrole derivatives and medicaments | |
| RS49711B (sr) | Postupak za dobijanje 1,4- dihidropiridina i jedinjenja koja se primenjuju u tom postupku | |
| Campaigne et al. | Synthesis of β-Dimethylaminoethyl and α-Hydroxy-β-Dimethylaminoethyl Derivatives from Organolithium Compounds and Tetramethyoxamide | |
| Kriis et al. | Asymmetric synthesis of 2, 3, 4-trisubstituted piperidines | |
| SK158195A3 (en) | Application of 5-acyl-1,4-dihydropyridines, 5-acyl- -1,4-dihydropyridines, manufacturing process thereof and pharmaceutical compositions containing them | |
| NZ511157A (en) | Derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol | |
| EP0009465A1 (de) | N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen | |
| ES8703429A1 (es) | Un procedimiento para la preparacion de una 1,4-dihidropiridina | |
| SU569280A3 (ru) | Способ получени аралкиловых эфиров аминокислот или их солей | |
| KR900006289A (ko) | 염기성 4-아릴-dhp 아미드, 그의 제조 방법 및 의약품으로서 그의 용도 | |
| Hathaway et al. | A new, potent, conformationally-restricted analog of amphetamine: 2-amino-1, 2-dihydronaphthalene | |
| Hasegawa et al. | Development of new chiral auxiliary derived from (S)-(-)-phenylethylamine for a synthesis of enantiopure (R)-2-propyloctanoic acid | |
| EA200000527A3 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| SK67295A3 (en) | Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them | |
| HU176277B (en) | Process for producing cycloalkyl-amine derivatives | |
| Iqbal et al. | Enantioselective syntheses and calcium channel modulating effects of (+)‐and (−)‐3‐isopropyl 5‐(4‐methylphenethyl) 1, 4‐dihydro‐2, 6‐dimethyl‐4‐(2‐pyridyl)‐3, 5‐pyridinedicarboxylates | |
| WO2023054626A1 (ja) | シクロプロパンアミド誘導体 | |
| KR20100079943A (ko) | 키랄 촉매를 이용한 아스파르트산 유도체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date |